Mayo, Tiffany, April Armstrong, Leon Kircik, Jonathan Silverberg, Andrew Blauvelt, Ben Esdaile, Shannon Schneider, Thomas Mark, Melinda Gooderham, and Andrew Alexis. “Efficacy and Safety of up to Two Years of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s144. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/2025.